Drug Type Small molecule drug |
Synonyms AZ 9482, AZ-9482 |
Target |
Mechanism PARP1 inhibitors(Poly (ADP-Ribose) polymerase 1 inhibitors), PARP2 inhibitors(Poly (ADP-Ribose) Polymerase 2 inhibitors), PARP6 inhibitors(poly(ADP-ribose) polymerase family member 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H22N6O2 |
InChIKeyZDDPBFWHZOJFHF-UHFFFAOYSA-N |
CAS Registry1825345-33-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | GB | 21 Feb 2020 | |
Breast Cancer | Preclinical | GB | 21 Feb 2020 |